We assessed the prognostic value of the induced response to programmed ventricular stimulation in a prospective study of clinically stable survivors of acute myocardial infarction. We also used a stepwise
In survivors of acute myocardial infarction mortality in the first year after discharge from hospital varies from 7 to 11 % .'-' Sudden cardiac death accounts for about half of the deaths and is probably caused by ventricular tachycardia or fibrillation. In recent years several investigators have examined the value of programmed ventricular stimulation in identifying a subset at an increased risk of sudden death,"' but the results have been conflicting. Moreover, none of the reported studies used a standard stimulation protocol of three extrastimuli or compared the prognostic significance of inducible ventricular arrhythmias with that of other prognostic variables.
We assessed the prognostic value of the induced response to programmed ventricular stimulation in a prospective study of clinically stable survivors of acute myocardial infarction. We also used a stepwise
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Accepted for publication 20 December 1988 Cox regression analysis to assess the value of programmed ventricular stimulation against other known clinical, electrocardiographic, and angiographic prognostic variables.
Patients and methods
Patients aged < 70 years admitted to the intensive cardiac care unit ofour hospital with a diagnosis ofan acute myocardial infarction were screened for the study. Myocardial infarction was diagnosed according to clinical, electrocardiographic, and enzymatic criteria. Patients were eligible if they were clinically stable and did not have Killip class III or IV congestive heart failure, moderate to severe angina pectoris, or spontaneous sustained ventricular tachycardia in the 48 hours after myocardial infarction. Patients were excluded if they had end stage disease of another organ system or if they refused to participate in the study.
From 
METHODS
After giving their written informed consent patients had 24 hour ambulatory electrocardiographic monitoring, programmed ventricular stimulation, and cardiac catheterisation with coronary angiography. These tests were performed within 7-18 (11 (3)) days after the infarct. Programmed ventricular stimulation and cardiac catheterisation were performed together on the same day after an average of 14 (5) days (9-21 days) after the infarct.
Programmed ventricular stimulation was performed with patients in the postabsorptive and unsedated state. Surface electrocardiographic leads (VI, I, and aVF) and intracardiac electrograms were displayed and recorded on an oscilloscopic photographic recorder (Electronics for Medicine, VR-16) at a paper speed of 25 mm/s. Stimuli of 2 ms at twice the diastolic threshold (minimum pacing current, 1-5 mA) were provided by a digital programmable stimulator (Bloom and Associates). The stimulation protocol was uniform in each patient and has been described in detail previously.'0 Briefly, the stimulation was always started at the right ventricular apex with burst pacing (500-280 ms) followed by a sequential insertion of single and double extrastimuli 11 patients, three extrastimuli in seven patients, and burst pacing in one patient. Induction of ventricular fibrillation required two extrastimuli in six patients and three extrastimuli in eight patients.
Programmed ventricular stimulation did not induce sustained ventricular arrhythmias in 42 patients (group 2). In six of them non-sustained ventricular tachycardia was induced (uniform in four patients and multiform in two). Induction required two extrastimuli in two patients and triple extrastimuli in four patients. Table 2 summarises the clinical, haemodynamic, and angiographic characteristics of patients in each group. Group 1 patients had an increased frequency of mild congestive heart failure, and a higher value for peak serum creatine kinase, pulmonary artery wedge pressure, and left ventricular wall motion abnormality score. However, the two groups did not significantly differ for 24 hour ambulatory electrocardiographic monitoring or treadmill testing, location of the infarct, left ventricular angiographic ejection fraction, and the frequency ofleft ventricular aneurysms.
FOLLOW UP OBSERVATIONS AND TREATMENT
The follow up ranged from four to 36 (18 (7)) months and was complete in all but five patients (two in group -4) (fig la) . Among group 1 patients, three patients died suddenly 15, 16, and 26 months after the index infarct and two patients had spontaneous sustained ventricular tachycardia at two weeks and 26 months after the infarct. Three extrastimuli were required to induce sustained arrhythmias in two of these five patients. Arrhythmic events did not develop in any ofthe nine patients in whom induction of sustained arrhythmias had required left ventricular stimulation. One patient in group 2 died suddenly three months after the index infarct and one had spontaneous sustained ventricular tachycardia two months after the infarct. The maximum induced response in both patients was less than three repetitive ventricular beats.
The risk of arrhythmic events was highest in a subset of 19 group 1 patients in whom sustained ventricular tachycardia was induced. Arrhythmic events occurred in four (three sudden deaths and one sustained ventricular tachycardia) of these 19 patients compared with three of the remaining 56 patients in whom arrhythmia was not inducible or in whom only ventricular fibrillation was induced. The study. We used a maximum of three extrastimuli
delivered at both right and left ventricles. In con-0-----------------trast, in most of the earlier studies a maximum oftwo A stepwise Cox regression analysis showed that mild those of three previous studies that evaluated the congestive heart failure was the only significant prognostic significance of programmed ventricular predictor (p < 0s0) of the subsequent arrhythmic stimulation in clinically stable survivors of acute events. There were arrhythmic events in four (29fo) myocardial infarction.7' In these studies, however, of the 14 patients with mild congestive heart failure the stimulation protocol included a maximum of two and three (5%) ofthe remaining 61 patients. The two extrastimuli at twice diastolic threshold; conceivably, year probability of remaining free of arrhythmic the lack of programmed ventricular stimulation may events was 0-76 in patients with and 0-94 in those have lacked predictive value because the stimulation without heart failure (p < 0-02) (fig 2) . In the protocol was inadequate. Indeed, in our study, two of prediction of future arrhythmic events the presence the five group 1 patients in whom arrhythmic events of mild congestive heart failure had a sensitivity, developed had required triple extrastimuli for inducspecificity, and positive predictive accuracy of 57%, tion of sustained arrhythmia, but triple extrastimuli 85%, and 28% respectively. also resulted in a much higher incidence (44%) of Among group 1 patients there was no significant inducibility. Arrhythmic events did not develop in difference in the occurrence of arrhythmic events in any of the nine group 1 patients who had required left patients who had received previous antiarrhythmic ventricular stimulation for induction of sustained treatment and those who had not (20% v 13%, ventricular tachycardia or ventricular fibrillation. p = NS). None of the 1 The configuration of the induced arrhythmia seemed to be of prognostic significance. probability of developing arrhythmic events within two years of infarction. In both studies, the patients with inducible ventricular tachycardia who developed arrhythmic events tended to have a longer cycle length for the induced ventricular tachycardia and a lower left ventricular ejection fraction. These findings were not unexpected and accord with the experimental observations in a canine model of myocardial infarction.'9 During serial programmed ventricular stimulation in 20 anaesthetised dogs, Garan et al showed a high week to week reproducibility (>90%) of inducible sustained uniform ventricular tachycardia, whereas induction of ventricular fibrillation was found to be a nonspecific response.'9 These findings also accord with observations in human beings where day to day reproducibility has been shown to be high for sustained ventricular tachycardia and low for ventricular fibrillation induced in the post-infarction period.20 CLINICAL IMPLICATIONS To be useful for identifying patients at risk of arrhythmic events, a test should have a high sensitivity and positive predictive accuracy and should also provide prognostic information independent ofa routine clinical evaluation. In the present study, inducible sustained ventricular tachycardia had a low sensitivity (57%o) and positive predictive accuracy (21%) for future arrhythmic events. Instead, outcome was best predicted by the presence or absence ofmild congestive heart failure. Had we excluded the 14 patients with mild congestive heart failure from our study, programmed ventricular stimulation in the remaining 61 patients would have identified only one patient in whom an arrhythmic event developed. In previous prospective studies of programmed ventricular stimulation, the positive predictive accuracy of programmed ventricular stimulation was 18% and 32%,X" and no study so far has shown the inducible arrhythmia to be an independent predictor of arrhythmic events. Moreover, programmed ventricular stimulation is an invasive and expensive test associated with a small but definite morbidity which can be performed at only a few laboratories with a highly trained staff. For these reasons, we believe that the routine use of this procedure is not recommended in clinically stable patients surviving an acute myocardial infarction. However, programmed ventricular stimulation may be of more value in patients whose post-infarction course is complicated by heart failure, angina pectoris, or ventricular tachycardia. A prospective study in such a high risk subset is already in progress at our medical centre. Among the first 53 patients studied, major arrhythmic events occurred in five of 10 patients with inducible sustained ventricular tachycardia and two of 43 (4-8%) patients in whom ventricular arrhythmias were non-inducible or who had induction of ventricular fibrillation (p < 0.01).2" These preliminary findings, though encouraging, need to be confirmed in a larger cohort of patients.
CRITIQUE OF THE STUDY
In this study, 10 of the 33 patients with inducible sustained arrhythmias received empirical antiarrhythmic treatment for the first 3-6 months, and this might have influenced outcome. However, no previous study has shown a beneficial effect of prophylactic antiarrhythmic treatment on survival in such patients. Moreover, antiarrhythmic treatment was not based on the results of electropharmacological testing, and two of these 10 patients had an arrhythmic event during follow up. f Adrenergic blocking agents were administered to only seven patients for control of angina or systemic hypertension. The outcome ofthe study population might also have been altered by the coronary artery bypass surgery, percutaneous transluminal coronary angioplasty, or both, which were performed in 11 patients (15%). Although none of these 11 patients had an arrhytlimic event during follow up, the number of patients undergoing coronary reperfusion was too small to draw a meaningful conclusion. Also, there was no significant difference in the proportion of 
